Intravascular imaging

World’s First Intracranial Use of a New High-Frequency Imaging System to Directly Visualize Neurovascular Pathologies

Retrieved on: 
Thursday, January 12, 2023
Health, Technology, Neurology, Hospitals, Health Technology, Radiology, Artificial Intelligence, Pathology, X-ray, Brain, ST, ICAD, ABC, Angiography, Hospital, Research, AI, Aneurysm, Neuro, Conference, Health, Diagnosis, Radiology, Patient, Intravascular imaging, Stroke, Unity Health Toronto, El Equipo, Innovation, HF, Medical imaging, MD

Gentuity , LLC, an advanced imaging technology firm, today announced the first human use of the Vis-MTM High-Frequency Optical Coherence Tomography (HF-OCT) imaging system and probe.

Key Points: 
  • Gentuity , LLC, an advanced imaging technology firm, today announced the first human use of the Vis-MTM High-Frequency Optical Coherence Tomography (HF-OCT) imaging system and probe.
  • This represents a significant technological advance for the field of neurointervention, making high resolution intravascular imaging in the brain possible.
  • The direct visualization technology we evaluated here offers unprecedented potential in the diagnosis and treatment of aneurysms, stroke, intra-cranial atherosclerotic disease (ICAD) and other neurological pathologies,” said Vitor Mendes Pereira, MD.
  • “Revolutions in neurointerventional imaging, from the discovery of x-rays over 120 years ago, to 3-dimensional imaging in the angiography suite 20 years ago, occur roughly once in a generation.

Xenter, Inc., Announces Company Launch and Strategy as the First Start-Up “Device/Data/Drug” Medical Technology Company

Retrieved on: 
Wednesday, April 7, 2021
Electronic design automation, Data management, Technology, Radiology, Oncology, Philanthropy, Medical devices, Clinical trials, Cardiology, Foundation, Science, Software, Other Science, Research, Health, Mobile, Wireless, Medical imaging, Intravascular imaging, Imaging

According to Linder, Xenter is developing radically innovative medical devices using Xenters sensors and signals technology that enables wireless physiologic data collection, wireless intravascular imaging, and software technologies for the treatment of heart and vascular disease.

Key Points: 
  • According to Linder, Xenter is developing radically innovative medical devices using Xenters sensors and signals technology that enables wireless physiologic data collection, wireless intravascular imaging, and software technologies for the treatment of heart and vascular disease.
  • Xenter expects the resulting instrumentation and strategies to drive a generational improvement in the efficiency and effectiveness of interventional medicine.
  • Linder has also been instrumental in advancing the life science industry, both at large and specifically in the Utah ecosystem.
  • He is the Founder and Chairman Emeritus of BioUtah, Utahs independent life science association representing Utahs medical device, drug discovery and diagnostic companies.

Conavi Medical and Japan Lifeline Announce MHLW Approval of Novasight Hybrid Intravascular Imaging System for Japanese Market

Retrieved on: 
Wednesday, February 19, 2020
General Health, Health, Other Technology, Technology, Cardiology, Medical imaging, Medicine, Clinical medicine, Medical physics, Intravascular imaging, Intravascular ultrasound, Optical coherence tomography, Tomography, Intravascular fluorescence, Conavi Medical, Japan Lifeline Co., Ltd.

ConaviTM Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight HybridTM intravascular imaging system.

Key Points: 
  • ConaviTM Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight HybridTM intravascular imaging system.
  • The Novasight Hybrid system is the worlds first clinical system capable of providing both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) on a single imaging catheter.
  • Japan Lifeline is the exclusive distributor for this technology in Japan.
  • Dr. Brian Courtney, Conavi Medicals Chief Executive Officer, comments that "We are delighted to have received MHLW approval of the Novasight Hybrid system.

Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE

Retrieved on: 
Friday, September 27, 2019
Cardiology, Biotechnology, Pharmaceutical, Health, General Health, Medical devices, Medical imaging, Intravascular ultrasound, Medical ultrasonography, Intravascular imaging

In April 2019, due to the positive results from the LRP study data, the FDA expanded the indications for use of the MakotoTM Intravascular Imaging System to include the identification of patients and plaques at increased risk of MACE.

Key Points: 
  • In April 2019, due to the positive results from the LRP study data, the FDA expanded the indications for use of the MakotoTM Intravascular Imaging System to include the identification of patients and plaques at increased risk of MACE.
  • Intravascular NIRS was developed, validated, and labeled for the detection of lipid core plaque (LCP).
  • They added that IVUS+NIRS, should be considered as a tool to guide patients and lesions at risk for unanticipated subsequent MACE.
  • The ability to detect LCP in order to stratify at-risk patients will enable cardiologists to make more personalized clinical decisions for their patients.

$1.12 Bn Optical Coherence Tomography (OCT) Market - Global Outlook & Forecasts 2017-2026

Retrieved on: 
Thursday, February 7, 2019
Medical imaging, Medicine, Clinical medicine, Medical physics, Laser medicine, Medical equipment, Optical coherence tomography, Optical imaging, Optics, Tomography, Intravascular fluorescence, Intravascular imaging

The "Optical Coherence Tomography (OCT) - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Optical Coherence Tomography (OCT) - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
  • Growing geriatric population, rising incidences of skin and neurology based disorders, demand for non-radiation imaging modalities and increasing patient awareness are some key factors propelling the market growth.
  • However, factors such as insufficient clinical data and lack of reimbursement facilities are inhibiting the growth of the market.
  • Optical Coherence Tomography (OCT) is a promising technology for performing high-resolution cross-sectional imaging.

InnovHeart Appoints Jason M. Bottiglieri as New Chief Executive Officer and Member of the Board

Retrieved on: 
Wednesday, December 19, 2018
Medicine, Medical imaging, RTT, Intravascular imaging, Coronary artery disease, Bottiglieri

Former CEO and founder, Giovanni Righini, will continue to serve the company as Chief Technology Officer and as member of the Board.

Key Points: 
  • Former CEO and founder, Giovanni Righini, will continue to serve the company as Chief Technology Officer and as member of the Board.
  • Jason Bottiglieri has more than 22 years of experience in the medical device industry including 18 in the interventional cardiovascular market.
  • Before joining InnovHeart, Mr. Bottiglieri was Chief Executive Officer of Infraredx, a start-up company developing a novel intravascular imaging system for the detection of lipid core plaque in coronary artery disease.
  • InnovHeart is backed by leading investor Genextra S.p.A, Italian holding company specialized in early-stage investments in the life sciences sector.